Humana (HUM) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Humana · Health Care · ref. ETF XLV · 50 calls · price $420.38
What the company does: Humana Inc. provides medical and specialty insurance products in the United States.
📈 Humana (HUM) stock price
$420.38+60.7% over range
Oct 14, 25low $163.67 · high $433.5Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
56% recommend buying · 18 analysts
📊 JPI status : Humana has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 HUM price target & analyst consensus — price $420
The price target · all analysts combined (18 targets)
Highest target · 1 firm of 18$596+41.8%
Median target · of 18 targets$473+12.5%
Lowest target · 1 firm of 18$254-39.6%
Current price$420.38
Where these 18 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1267%
$441 ↔ $596
Below
633%
$254 ↔ $415
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (830 calls tested). It aims for $370 (-12 %), call made on August 6, 2026, maturing on August 6, 2027 (69 d ago).
The 12 reliable analysts
$488+16 %
The 6 other firms
$428+1.8 %
How to read it: the 12 reliable firms are not filtered by optimism — 9 aim above the price, 3 below, hence their $488 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 18 ratings (last 6 months)
Strong Buy00%
Buy1056%
Hold844%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 HUM price target all
All 18 calls, one by one, with our verdict on each firm.
→ See all 18 targets, analyst by analyst💡 The best analysts on HUM most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in HUM? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Humana? The JPI assistant answers using our backtest data.
💰 Humana dividend: yield, history & growth › open the full page
0.86%annual yield
That's ~$3.54 per share per year.
📈 Humana fundamentals: valuation, margins & growth › open the full page
P/E 39.7Net margin 0.9 %Revenue growth +26.2 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 3 %
2023
Rev +15%Profit −11%
2024
Rev +11%Profit −52%
2025
Rev +10%Profit −2%
🔎 Detailed analyses
🏛️ Which US Congress members hold Humana (HUM)?
5 Congress members have disclosed HUM buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on HUM
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Stifel ↗ | 100% | +58.1% | 2 |
| Raymond James ↗ | 100% | +48.3% | 2 |
| Monness, Crespi, Hardt | 100% | +36.3% | 3 |
| Bernstein ↗ | 100% | +24.1% | 2 |
| SVB Leerink | 78% | +7.9% | 9 |
| JP Morgan ↗ | 77% | +18.9% | 13 |
| Leerink Swann | 75% | +15.5% | 4 |
| Wells Fargo ↗ | 73% | +12.6% | 11 |
| BMO Capital ↗ | 67% | +21.3% | 3 |
| Barclays ↗ | 67% | +17.1% | 6 |
See the other 18 firms
| TD Cowen ↗ | 0% | -30.3% | 4 |
| Deutsche Bank ↗ | 17% | -23.7% | 6 |
| Stephens & Co. ↗ | 17% | -21.8% | 6 |
| Cantor Fitzgerald ↗ | 25% | -20.0% | 8 |
| RBC Capital ↗ | 29% | -10.5% | 17 |
| Goldman Sachs ↗ | 33% | -11.6% | 9 |
| Oppenheimer ↗ | 33% | -6.5% | 12 |
| UBS ↗ | 33% | -6.4% | 3 |
| Argus Research ↗ | 40% | +1.1% | 5 |
| Piper Sandler ↗ | 40% | +4.7% | 5 |
| Mizuho ↗ | 44% | +5.9% | 9 |
| Cowen & Co. | 50% | +0.6% | 2 |
| Guggenheim ↗ | 50% | +1.5% | 2 |
| B of A Securities ↗ | 50% | +13.0% | 4 |
| Citigroup ↗ | 56% | +3.6% | 9 |
| Credit Suisse | 60% | +2.9% | 10 |
| Morgan Stanley ↗ | 62% | +11.9% | 21 |
| Jefferies ↗ | 64% | +14.2% | 14 |
📊 What $1,000 invested in Humana would be worth › open the full page
In short — $1,000 invested in Humana 10 years ago would be worth $2,245 today, i.e. +8%/yr on average. Best year: 2017 (+29%), worst: 2025 (-30%). Price performance, excluding dividends.
If I'd invested $1,000 in Humana
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,469 | +47% |
| 3 years ago | $802 | -20% |
| 5 years ago | $1,046 | +5% |
Return by year (Humana)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +108% | $2,085 (+108%) |
| 2025 | -30% | $1,469 (+47%) |
| 2024 | -23% | $1,134 (+13%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Humana
Loading news…
📋 All analyst calls on HUM
Filtered on — · ✕ show all
▲ Outperform · 🎯$495
Price at call : $420.38 — upside +18%
Today : $420.38 — upside +18%
🎯 on HUM : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
■ Neutral neutral · not a buy · 🎯$495
Price at call : $420.38 — gap to target +18%
Today : $420.38 — gap to target +18%
🎯 on HUM : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
Truist Securities ↗
Oct 12, 26
■ Hold neutral · not a buy · 🎯$475
Price at call : $420.38 — gap to target +13%
Today : $420.38 — gap to target +13%
🎯 on HUM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
Oppenheimer ↗
Oct 12, 26
▲ Outperform · 🎯$525
Price at call : $420.38 — upside +25%
Today : $420.38 — upside +25%
🎯 on HUM : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
Raymond James ↗
Oct 12, 26
▲ Outperform · 🎯$520
Price at call : $433.5 — upside +20%
Today : $420.38 — upside +24%
🎯 on HUM : no call matured yet · 📊 on Health : 46.4% · +1.6% (403 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
▲ Overweight · 🎯$582
Price at call : $433.5 — upside +34%
Today : $420.38 — upside +38%
🎯 on HUM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 9, 27
matures : Oct 9, 27
Oppenheimer ↗
Oct 9, 26
▲ Outperform · 🎯$475
Price at call : $433.5 — upside +10%
Today : $420.38 — upside +13%
🎯 on HUM : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Oct 9, 27
matures : Oct 9, 27
▲ Outperform · 🎯$596
Price at call : $431.87 — upside +38%
Today : $420.38 — upside +42%
🎯 on HUM : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Oct 9, 27
matures : Oct 9, 27
See the other 42 calls, newest to oldest
Cantor Fitzgerald ↗
Oct 7, 26
▲ Overweight · 🎯$460
Price at call : $396.51 — upside +16%
Today : $420.38 — upside +9%
🎯 on HUM : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
▲ Overweight · 🎯$515
Price at call : $389.63 — upside +32%
Today : $420.38 — upside +23%
🎯 on HUM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Sep 25, 27
matures : Sep 25, 27
■ Neutral neutral · not a buy · 🎯$393
Price at call : $372.82 — gap to target +5%
Today : $420.38 — gap to target -7%
🎯 on HUM : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
Morgan Stanley ↗
Aug 5, 26
■ Equal-Weight neutral · not a buy · 🎯$370
Price at call : $363.82 — gap to target +2%
Today : $420.38 — gap to target -12%
🎯 on HUM : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
■ Hold neutral · not a buy · 🎯$370
Price at call : $374.5 — gap to target -1%
Today : $420.38 — gap to target -12%
🎯 on HUM : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Equal-Weight neutral · not a buy · 🎯$407
Price at call : $363.86 — gap to target +12%
Today : $420.38 — gap to target -3%
🎯 on HUM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Neutral neutral · not a buy · 🎯$405
Price at call : $363.86 — gap to target +11%
Today : $420.38 — gap to target -4%
🎯 on HUM : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Evercore ISI Group ↗
Jul 30, 26
▲ Outperform · 🎯$480
Price at call : $363.86 — upside +32%
Today : $420.38 — upside +14%
🎯 on HUM : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Guggenheim ↗
Jul 30, 26
▲ Buy · 🎯$471
Price at call : $363.86 — upside +29%
Today : $420.38 — upside +12%
🎯 on HUM : no call matured yet · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Raymond James ↗
Jul 30, 26
■ Market Perform neutral · not a buy
🎯 on HUM : no call matured yet · 📊 on Health : 46.4% · +1.6% (403 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
■ Hold neutral · not a buy · 🎯$350
Price at call : $407.78 — gap to target -14%
Today : $420.38 — gap to target -17%
🎯 on HUM : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Truist Securities ↗
Jul 14, 26
■ Hold neutral · not a buy · 🎯$415
Price at call : $407.78 — gap to target +2%
Today : $420.38 — gap to target -1%
🎯 on HUM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Wells Fargo ↗
Jul 13, 26
▲ Overweight · 🎯$502
Price at call : $406 — upside +24%
Today : $420.38 — upside +19%
🎯 on HUM : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
RBC Capital ↗
Jul 9, 26
■ Sector Perform neutral · not a buy · 🎯$415
Price at call : $392.22 — gap to target +6%
Today : $420.38 — gap to target -1%
🎯 on HUM : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Cantor Fitzgerald ↗
Jul 7, 26
■ Neutral neutral · not a buy · 🎯$300
Price at call : $394.62 — gap to target -24%
Today : $420.38 — gap to target -29%
🎯 on HUM : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
B of A Securities ↗
Jun 24, 26
■ Neutral neutral · not a buy · 🎯$380
Price at call : $376 — gap to target +1%
Today : $420.38 — gap to target -10%
🎯 on HUM : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
Evercore ISI Group ↗
Jun 11, 26
■ In-Line neutral · not a buy · 🎯$370
Price at call : $379.22 — gap to target -2%
Today : $420.38 — gap to target -12%
🎯 on HUM : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
▲ Outperform · 🎯$390
Price at call : $363.18 — upside +7%
Today : $420.38 — upside -7%
🎯 on HUM : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jun 8, 27
matures : Jun 8, 27
■ Neutral neutral · not a buy · 🎯$316
Price at call : $363.18 — gap to target -13%
Today : $420.38 — gap to target -25%
🎯 on HUM : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Jun 8, 27
matures : Jun 8, 27
B of A Securities ↗
Jun 4, 26
■ Neutral neutral · not a buy · 🎯$340
Price at call : $350.08 — gap to target -3%
Today : $420.38 — gap to target -19%
🎯 on HUM : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Morgan Stanley ↗
Jun 4, 26
▼ Underweight · 🎯$249
Price at call : $350.08 — upside -29%
Today : $420.38 — upside -41%
🎯 on HUM : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Truist Securities ↗
Jun 1, 26
■ Hold neutral · not a buy · 🎯$320
Price at call : $320.88 — gap to target -0%
Today : $420.38 — gap to target -24%
🎯 on HUM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
■ Equal-Weight neutral · not a buy · 🎯$344
Price at call : $306.27 — gap to target +12%
Today : $420.38 — gap to target -18%
🎯 on HUM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
■ Neutral neutral · not a buy · 🎯$320
Price at call : $301.69 — gap to target +6%
Today : $420.38 — gap to target -24%
🎯 on HUM : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
▲ Outperform · 🎯$335
Price at call : $304.1 — upside +10%
Today : $420.38 — upside -20%
🎯 on HUM : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : May 20, 27
matures : May 20, 27
Deutsche Bank ↗
May 20, 26
▲ Buy · 🎯$441
Price at call : $304.1 — upside +45%
Today : $420.38 — upside +5%
🎯 on HUM : no call matured yet · 📊 on Health : 53.1% · +4.5% (292 calls)
in progress (365j)
matures : May 20, 27
matures : May 20, 27
Morgan Stanley ↗
May 15, 26
▼ Underweight · 🎯$217
Price at call : $305.12 — upside -29%
Today : $420.38 — upside -48%
🎯 on HUM : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : May 15, 27
matures : May 15, 27
Piper Sandler ↗
May 13, 26
■ Neutral neutral · not a buy · 🎯$254
Price at call : $304.85 — gap to target -17%
Today : $420.38 — gap to target -40%
🎯 on HUM : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : May 13, 27
matures : May 13, 27
■ Hold neutral · not a buy · 🎯$211
Price at call : $237.96 — gap to target -11%
Today : $420.38 — gap to target -50%
🎯 on HUM : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
■ Neutral neutral · not a buy · 🎯$214
Price at call : $237.96 — gap to target -10%
Today : $420.38 — gap to target -49%
🎯 on HUM : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
■ Neutral neutral · not a buy · 🎯$262
Price at call : $233.63 — gap to target +12%
Today : $420.38 — gap to target -38%
🎯 on HUM : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
RBC Capital ↗
Apr 30, 26
■ Sector Perform neutral · not a buy · 🎯$246
Price at call : $233.63 — gap to target +5%
Today : $420.38 — gap to target -41%
🎯 on HUM : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
Guggenheim ↗
Apr 30, 26
▲ Buy · 🎯$269
Price at call : $233.63 — upside +15%
Today : $420.38 — upside -36%
🎯 on HUM : no call matured yet · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
■ Equal-Weight neutral · not a buy · 🎯$180
Price at call : $233.63 — gap to target -23%
Today : $420.38 — gap to target -57%
🎯 on HUM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
Evercore ISI Group ↗
Apr 30, 26
■ In-Line neutral · not a buy · 🎯$250
Price at call : $233.63 — gap to target +7%
Today : $420.38 — gap to target -41%
🎯 on HUM : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
Truist Securities ↗
Apr 30, 26
■ Hold neutral · not a buy · 🎯$270
Price at call : $236.44 — gap to target +14%
Today : $420.38 — gap to target -36%
🎯 on HUM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Apr 30, 27
matures : Apr 30, 27
Truist Securities ↗
Apr 13, 26
■ Hold neutral · not a buy · 🎯$220
Price at call : $196.21 — gap to target +12%
Today : $420.38 — gap to target -48%
🎯 on HUM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Evercore ISI Group ↗
Apr 8, 26
■ In-Line neutral · not a buy · 🎯$195
Price at call : $197.32 — gap to target -1%
Today : $420.38 — gap to target -54%
🎯 on HUM : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Wells Fargo ↗
Apr 7, 26
■ Equal-Weight neutral · not a buy · 🎯$227
Price at call : $198.39 — gap to target +14%
Today : $420.38 — gap to target -46%
🎯 on HUM : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Apr 7, 27
matures : Apr 7, 27
■ Equal-Weight neutral · not a buy · 🎯$176
Price at call : $186.83 — gap to target -6%
Today : $420.38 — gap to target -58%
🎯 on HUM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Wells Fargo ↗
Feb 18, 26
■ Equal-Weight neutral · not a buy · 🎯$206
Price at call : $187.12 — gap to target +10%
Today : $420.38 — gap to target -51%
🎯 on HUM : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
Goldman Sachs ↗
Feb 17, 26
▼ Sell · 🎯$158
Price at call : $187.12 — upside -16%
Today : $420.38 — upside -62%
🎯 on HUM : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
Frequently asked questions
Should I buy Humana stock?
This isn't buy advice. For Humana, the analyst consensus is "Buy", with an average price target of $473 (+13% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Humana). We show the numbers — you decide.
Is it too late to buy Humana? How high can it go?
The most bullish analyst target on Humana is $596 (+42% above today's price); the average is $473. That's the upside they see. Check how reliable those analysts have actually been on Humana on our site before trusting it.
Is Humana still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 28 analysts have a real record on Humana, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Humana? The case for and against
The arguments for and against, one by one, from the numbers: why invest in HUM (and why hesitate).
What has Humana's past performance been?
Historical returns and a "how much if I had invested" calculator: HUM performance & returns.
Does Humana pay a dividend?
Yield, consistency and growth history of the dividend: HUM's dividend.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX